These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19884074)

  • 1. Computerized image-based detection and grading of lymphocytic infiltration in HER2+ breast cancer histopathology.
    Basavanhally AN; Ganesan S; Agner S; Monaco JP; Feldman MD; Tomaszewski JE; Bhanot G; Madabhushi A
    IEEE Trans Biomed Eng; 2010 Mar; 57(3):642-53. PubMed ID: 19884074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expectation-maximization-driven geodesic active contour with overlap resolution (EMaGACOR): application to lymphocyte segmentation on breast cancer histopathology.
    Fatakdawala H; Xu J; Basavanhally A; Bhanot G; Ganesan S; Feldman M; Tomaszewski JE; Madabhushi A
    IEEE Trans Biomed Eng; 2010 Jul; 57(7):1676-89. PubMed ID: 20172780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-aided prognosis: predicting patient and disease outcome via quantitative fusion of multi-scale, multi-modal data.
    Madabhushi A; Agner S; Basavanhally A; Doyle S; Lee G
    Comput Med Imaging Graph; 2011; 35(7-8):506-14. PubMed ID: 21333490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-aided classification of breast cancer nuclei.
    Schnorrenberg F; Pattichis CS; Schizas CN; Kyriacou K; Vassiliou M
    Technol Health Care; 1996 Aug; 4(2):147-61. PubMed ID: 8885093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
    Staaf J; Ringnér M; Vallon-Christersson J; Jönsson G; Bendahl PO; Holm K; Arason A; Gunnarsson H; Hegardt C; Agnarsson BA; Luts L; Grabau D; Fernö M; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
    J Clin Oncol; 2010 Apr; 28(11):1813-20. PubMed ID: 20231686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
    Tas F
    Onkologie; 2012; 35(3):95-8. PubMed ID: 22414972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifeature prostate cancer diagnosis and Gleason grading of histological images.
    Tabesh A; Teverovskiy M; Pang HY; Kumar VP; Verbel D; Kotsianti A; Saidi O
    IEEE Trans Med Imaging; 2007 Oct; 26(10):1366-78. PubMed ID: 17948727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Content-based image retrieval of digitized histopathology in boosted spectrally embedded spaces.
    Sridhar A; Doyle S; Madabhushi A
    J Pathol Inform; 2015; 6():41. PubMed ID: 26167385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLP-2 overexpression could serve as a prognostic factor in node positive and HER2 negative breast cancer.
    Cao W; Zhang B; Li J; Liu Y; Liu Z; Sun B
    Pathology; 2011 Dec; 43(7):713-8. PubMed ID: 22081131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis.
    Chen C; Xia HS; Gong YP; Peng J; Peng CW; Hu MB; Zhu XB; Pang DW; Sun SR; Li Y
    Biomaterials; 2010 Nov; 31(33):8818-25. PubMed ID: 20723971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A boosted Bayesian multiresolution classifier for prostate cancer detection from digitized needle biopsies.
    Doyle S; Feldman M; Tomaszewski J; Madabhushi A
    IEEE Trans Biomed Eng; 2012 May; 59(5):1205-18. PubMed ID: 20570758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.
    Ono M; Tsuda H; Shimizu C; Yamamoto S; Shibata T; Yamamoto H; Hirata T; Yonemori K; Ando M; Tamura K; Katsumata N; Kinoshita T; Takiguchi Y; Tanzawa H; Fujiwara Y
    Breast Cancer Res Treat; 2012 Apr; 132(3):793-805. PubMed ID: 21562709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting features of breast cancer with gene expression patterns.
    Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
    Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
    Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
    IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of breast tissues using Moran's index and Geary's coefficient as texture signatures and SVM.
    Braz Junior G; Cardoso de Paiva A; Corrêa Silva A; Cesar Muniz de Oliveira A
    Comput Biol Med; 2009 Dec; 39(12):1063-72. PubMed ID: 19800057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated diagnostics: a conceptual framework with examples.
    Madabhushi A; Doyle S; Lee G; Basavanhally A; Monaco J; Masters S; Tomaszewski J; Feldman M
    Clin Chem Lab Med; 2010 Jul; 48(7):989-98. PubMed ID: 20491597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of heterogeneous breast cancer with clonally expanded T-Cells in the HER2+ and metastasis of the HER2- tumor cells.
    Wiech T; Nikolopoulos E; Hausmann M; Walch A; Werner M; Fisch P
    Breast J; 2008; 14(5):487-91. PubMed ID: 18821935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.